PORTFOLIO
Supporting the development of tomorrow's vaccines
EVI's activities are diverse. We support and coordinate research into individual vaccine candidates, work across Europe to harmonise processes and protocols for vaccine development and strengthen the capacity for vaccine Research and Development in low- and middle-income countries.
-
Translational R&D & Capacity strengthening
-
Harmonisation
-
Control Testing
-
Networking & Policy
CROSS-CUTTING ACTIVITIES
VACCINE R&D
EVI supports a diverse portfolio of pre-clinical, early clinical, and advanced clinical projects. We strategically use our resources to support and advance a wide range of vaccine candidates as well as cross-cutting activities.
Vaccine R&D
VACCINE CANDIDATES
See below the vaccine candidate table targeting various stages in the development pipeline, and click on any of them to know more:
References:
* Candidates under selection for multi-stage approach
** Undisclosed combination
Lines indicate funding secured
*** Licensed vaccine assessed for alternative administration schedules
§ Evaluation in different demographics
Discovery
Pre-clinical proof of concept
Clinical proof of concept
Development
Phase I
Phase IIa
Phase IIb
Phase III
Phase IV
Placental malaria
Multi-stage vaccine
Blood stage
Transmission blocking
Pre-erythrocytic stage
Nipah virus infection
Influenza
COVID-19
Applied Vaccinology
CROSS-CUTTING ACTIVITES
We are committed to supporting vaccine development beyond individual vaccine candidates. We engage in initiatives aimed at creating harmonisation between stakeholders, promoting networking, developing innovative R&D solutions, and accessing vaccine infrastructure at the European and global level.
​
See below the Cross-cutting Activities table, and click on any of them to know more about each project:
Active projects
Closed projects
If you have any questions regarding our portfolio of vaccines candidates or cross-cutting projects, emails us to contact.us@euvaccine.eu.